Phase 1Data readout

HCW9302

Alopecia areata

HCWBHCW Biologics

Expected catalystDecember 31, 2026Company guidance: Dec 31, 2026

Catalyst overview

Event details

Drug or asset: HCW9302
Development stage: Phase 1
Event type: Data readout
Indication: Alopecia areata

Research signalsHigh management interest

Research summary

What is being tracked?

This catalyst tracks a Phase 1 data readout for HCW9302 in Alopecia areata. The expected timing is based on the latest available company guidance and may change.

Development notes

05/14/26:- Ph1 preliminary data remains due H1 2026; full readout expected Q4 2026. 06/16/26:- Positive; RP2D by Q4 2026; NCT07049328. 08/14/26:- Preliminary Phase 1 efficacy and safety data reported. Full Phase 1 data readout is expected in Q4 2026.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source